Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
Website: thermofisher.com


  • Pretty weak financial results growth rate 1.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-0.7%)
  • Dividend yield for the last twelve months 0.3%
  • Free cash flow yield -0.6% (LTM)
  • Share price is 46.7% higher than minimum and 8.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (23.3x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $19.8 mln (-0.009% of cap.)

Key Financials (Download financials)

Ticker: TMO
Share price, USD:  (+1.1%)572.41
year average price 489.62  


year start price 551.74 2024-11-10

max close price 606.74 2025-01-30

min close price 390.26 2025-06-17

current price 572.41 2025-11-09
Common stocks: 391 000 000

Dividend Yield:  0.3%
FCF Yield LTM: -0.6%
EV / LTM EBITDA: 23.3x
EV / EBITDA annualized: 27.4x
Last revenue growth (y/y):  +0.2%
Last growth of EBITDA (y/y):  +2.3%
Historical revenue growth:  +1.8%
Historical growth of EBITDA:  -3.2%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 223 812
Net Debt ($m): -5 849
EV (Enterprise Value): 217 963
EBITDA LTM ($m): 9 369
EV / LTM EBITDA: 23.3x
Price to Book: 4.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-10-29youtube.com

Sethi: Thermo Fisher is a world-class compounder you want in your portfolio

2025-10-29reuters.com

Thermo Fisher to buy clinical services provider Clario

2025-10-28globenewswire.com

14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge

2025-10-28reuters.com

Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports

2025-10-25seekingalpha.com

Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive

2025-10-22seekingalpha.com

Thermo Fisher Scientific: Now Fairly Valued Considering Growth Outlook (Rating Downgrade)

2025-10-22zacks.com

Q3 Earnings Bonanza Pulls a Flat Pre-Market: T, TMO, TSLA, etc.

2025-10-22zacks.com

Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates

2025-10-22reuters.com

Thermo Fisher beats third-quarter estimates on strong demand for lab tools

2025-10-17zacks.com

Countdown to Thermo Fisher (TMO) Q3 Earnings: Wall Street Forecasts for Key Metrics
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data